Unitex Tenamyd Canada Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue -76.16%
(FY 2021)
- Profit -91.74%
(FY 2021)
- Ebitda 72.30%
(FY 2021)
- Net Worth 1.91%
(FY 2021)
- Total Assets 4.87%
(FY 2021)
About Unitex Tenamyd Canada
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajan Dubey and Suchet Rastogi serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PTC162913
- Company No.
162913
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2006
- Date of AGM
19 Aug 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unitex Tenamyd Canada?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suchet Rastogi  | Director | 29-Jun-2006 | Current |
| Rajan Dubey | Director | 06-Feb-2020 | Current |
Financial Performance of Unitex Tenamyd Canada.
Unitex Tenamyd Canada Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 76.16% decrease. The company also saw a substantial fall in profitability, with a 91.74% decrease in profit. The company's net worth moved up by a moderate rise of 1.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unitex Tenamyd Canada?
In 2021, Unitex Tenamyd Canada had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Srs Unistraw Private LimitedActive 19 years 10 monthsRajan Dubey and Suchet Rastogi are mutual person
- Clesstra Healthcare Private LimitedActive 19 years 10 months
Rajan Dubey and Suchet Rastogi are mutual person
- Srs Therapeutics Private LimitedActive 18 years 7 months
Rajan Dubey and Suchet Rastogi are mutual person
- Mahakaushal Sugar And Power Industries LimitedActive 19 years 8 months
Rajan Dubey is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unitex Tenamyd Canada?
Unlock and access historical data on people associated with Unitex Tenamyd Canada, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unitex Tenamyd Canada, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitex Tenamyd Canada's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
